Type 2 Diabetes Trial, Recruiting (NCT05156736)

Type 2 Diabetes Trial, Recruiting NCT05156736 Sponsor: Tabba Heart Institute Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT05156736 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are native Pakistani
Men between the ages of 35 and 60, or women between the ages of 35 and 65
People who are willing to give their consent to take part in the trial

Who may not be able to join:

People whose kidneys are not filtering blood well enough (based on a measure called eGFR being below a certain level — confirm with trial site)
Women who are currently pregnant
People who have previously had a stroke or a heart attack, or who have had heart bypass surgery or a procedure to open blocked heart arteries
People who have a history of poor blood circulation in the legs or other limbs (peripheral arterial disease)
People who weigh more than 102 kilograms
People who currently have any active cancer
People who have a known medical reason why they cannot receive the dye used in a specialised heart scan (cardiac CTA)
People who are expected to move away from their current residential area within the next 5 years

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +92-21-36811841

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05156736

Sponsor: Tabba Heart Institute

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: +92-21-36811841

More information: https://clinicaltrials.gov/study/NCT05156736

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are native Pakistani
Men between the ages of 35 and 60, or women between the ages of 35 and 65
People who are willing to give their consent to take part in the trial

Who may not be able to join:

People whose kidneys are not filtering blood well enough (based on a measure called eGFR being below a certain level — confirm with trial site)
Women who are currently pregnant
People who have previously had a stroke or a heart attack, or who have had heart bypass surgery or a procedure to open blocked heart arteries
People who have a history of poor blood circulation in the legs or other limbs (peripheral arterial disease)
People who weigh more than 102 kilograms
People who currently have any active cancer
People who have a known medical reason why they cannot receive the dye used in a specialised heart scan (cardiac CTA)
People who are expected to move away from their current residential area within the next 5 years

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Tabba Heart Institute

Registry

ClinicalTrials.gov

Start date

15 March 2023

Est. completion

1 February 2028

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Burden of atherosclerotic plaque assessed via coronary computed tomography angiography

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov